Video
Discover the new IBA cyclotron, Cyclone® iKure
- 01/06/2026
IBA launches a new cyclotron, purpose-built for Astastine-211 production
IBA today launches Cyclone® iKure, a dedicated cyclotron for routine Astatine-211 (211At) production. Designed for alpha-beam irradiation, this new cyclotron enables radiopharmaceutical manufacturers, research institutions and healthcare providers to accelerate access to targeted alpha therapies with the reliability and quality required for clinical-scale programs.
Explore the specifications of Cyclone® iKure
Discover the IBA cyclotron designed for industrial scale 211At production.